MELANOMA PATIENTS AUSTRALIA SUBMISSION PBAC consideration of KEYTRUDA (pembrolizumab) Background of Melanoma Patients Australia (MPA) MPA is the only patient driven not for profit organisation in Australia that offers a

First Page		Document Content
Date: 2015-02-19 18:52:21 James A. Schlipmann Melanoma Cancer Foundation Melanoma Cancer organizations AIM at Melanoma Foundation		MELANOMA PATIENTS AUSTRALIA SUBMISSION PBAC consideration of KEYTRUDA (pembrolizumab) Background of Melanoma Patients Australia (MPA) MPA is the only patient driven not for profit organisation in Australia that offers a Add to Reading List Source URL: www.melanomapatients.org.au Download Document from Source Website File Size: 264,00 KB Share Document on Facebook